Mednet Logo
HomeHematologyQuestion

How do you counsel patients with newly diagnosed transplant-ineligible multiple myeloma on the expectations of treatment in terms of disease control, duration of therapy, monitoring and follow up?

3 Answers
Mednet Member
Mednet Member
Medical Oncology · University of Michigan

I'm going to take this question very literally and write a paraphrase of my general explanation to patients at an initial diagnosis and treatment planning visit. Forgive me, this is long, a paraphrase of a 30-60 minute visit with a patient. I hope this will result in others sharing how they navigate...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · Mayo Clinic

It is important to make sure patients understand that while long-term remissions are possible, myeloma appears to be incurable for the majority of patients. It is important to accurately risk stratify the patients so that they have a good understanding of the prognosis. It is also important to highl...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · Memorial Sloan Kettering Cancer Center

This is an ongoing conversation during the induction phase of therapy and reassessing their personal goals along the way. It is very important to have geri-onc management during their care, along with supportive care measures to manage bone health and infection risk.

Register or Sign In to see full answer

How do you counsel patients with newly diagnosed transplant-ineligible multiple myeloma on the expectations of treatment in terms of disease control, duration of therapy, monitoring and follow up? | Mednet